Global Flow Cytometry Market 2022 - Industry Briefing

October 2022 | 49 pages | ID: GA63B595DB58EN
Gen Consulting Company

Abstracts

Garnering a CAGR of 8.3% from 2022 to 2028, the global flow cytometry market is projected to reach worth of USD 8,893 million by 2028-end, according to a new report by Gen Consulting Company.

This industry report offers market estimates of the global market, followed by a detailed analysis of the product, technology, application, end user, and region. The global market data on flow cytometry can be segmented by product: kits and reagents, instruments, software and services, others. The kits and reagents segment held the largest share of the global flow cytometry market in 2021 and is anticipated to hold its share during the forecast period. Flow cytometry market is further segmented by technology: cell-based flow cytometry, bead-based flow cytometry. Globally, the cell-based flow cytometry segment made up the largest share of the flow cytometry market. Based on application, the flow cytometry market is segmented into: cancer, drug discovery, stem cell therapy, organ transplantation, hematologic malignancy, others. The cancer segment was the largest contributor to the global flow cytometry market in 2021. On the basis of end user, the flow cytometry market also can be divided into: hospitals and clinics, research institutes, pharmaceutical companies, others. The hospitals and clinics segment is estimated to account for the largest share of the global flow cytometry market. Flow cytometry market by region is categorized into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America.

The global flow cytometry market is highly competitive. The leading players in the flow cytometry market include Agilent Technologies Inc., Becton Dickinson and Company, BioMerieux SA, Bio-Rad Laboratories Inc., Danaher Corporation, Enzo Biochem Inc., Luminex Corporation, Miltenyi Biotec B.V. & CO. KG, Sysmex Corporation, Thermo Fisher Scientific Inc.

The data-centric report focuses on market trends, status and outlook for segments. With comprehensive market assessment across the major geographies, the report is a valuable asset for the existing players, new entrants and the future investors.

Why buy this report?

• Get a detailed picture of the Global Flow Cytometry Market
• Identify segments/areas to invest in over the forecast period in the Global Flow Cytometry Market
• Understand the competitive environment, the market’s leading players
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.

Contents

PART 1. SUMMARY

PART 2. INTRODUCTION

Study period
Geographical scope
Market segmentation

PART 3. FLOW CYTOMETRY MARKET OVERVIEW

PART 4. MARKET BREAKDOWN BY PRODUCT

Kits and reagents
Instruments
Software and services
Others

PART 5. MARKET BREAKDOWN BY TECHNOLOGY

Cell-based flow cytometry
Bead-based flow cytometry

PART 6. MARKET BREAKDOWN BY APPLICATION

Cancer
Drug discovery
Stem cell therapy
Organ transplantation
Hematologic malignancy
Others

PART 7. MARKET BREAKDOWN BY END USER

Hospitals and clinics
Research institutes
Pharmaceutical companies
Others

PART 8. MARKET BREAKDOWN BY REGION

North America
Europe
Asia-Pacific
MEA (Middle East and Africa)
Latin America

PART 9. KEY COMPANIES

Agilent Technologies, Inc.
Becton, Dickinson and Company
BioMerieux SA
Bio-Rad Laboratories Inc.
Danaher Corporation
Enzo Biochem Inc.
Luminex Corporation
Miltenyi Biotec B.V. & CO. KG
Sysmex Corporation
Thermo Fisher Scientific Inc.

PART 10. METHODOLOGY